To confirm the expression, immunofluorescence assays were performed as shown in Figures 6K–N that RBP4, S100A8, NPY, and CST1 were co-expressed with a conventional marker of fibroblasts (ACTA2) in different stages of stomach disease. Here, RBP4 is linked to stomach disorder.